Cellectar Shares Sharply Higher, Not Seeing Fundamental News; Co. Is Likely A Low-Float Play, Has 1.7M Shares In Float; Unknown Twitter Source Suggests Stock Is 'next direct sympathy of Bio-Path'; Benzinga Has Not Confirmed This Information